HOME_PAGE_HEADER_CONTENT
Learn More-HP Updated
Learn More
Featured News
Press Releases
Tue May 21 00:00:00 GMT-05:00 2024
NEW
Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO
Download
Mon Apr 29 00:00:00 GMT-05:00 2024
NEW
ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
Download
Fri Apr 05 00:00:00 GMT-05:00 2024
ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
Download
Wed Apr 03 00:00:00 GMT-05:00 2024
REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer
Download